We describe a case of non-menstrual streptococcal toxic shock syndrome requiring high doses of noradrenaline. The intravenous administration of pooled immunoglobulin was associated with improved haemodynamics and weaning of vasoconstrictors.
ConeL.A., WoodardD.R., SchlievertP.M., TomoryG.S.Clinical and bactieriological observations of a toxic shock-like syndrome due to streptococcus pyogenes.N Engl J Med1987; 317: 146–149.
ResnickS.D.Toxic shock syndrome: Recent developments in pathogenesis.J Pediatr1990; 116: 321–328.
5.
NadalD., LauenerR.P., BraeggerC.P.T-cell activation and cytokine release in Streptococcal toxic shock-like syndrome.J Pediatr1993; 122: 727–729.
6.
StevensD.L., TannerM.H., WinshipJ.Severe group A strep-tococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.N Engl J Med1989; 321: 1–7.
7.
PoindexterN.J., SchlievertP.M.Suppression of immuno-globulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1.J Infect Disease1986; 153: 772–779.
8.
BraunM.A., GerlachD., HartwigU.F.Stimulation of human T cells by streptococcal “superantigen” erythrogenic toxins (scarlet fever toxins).J Immunol1993; 150: 2457–2466.
9.
KaulR., McgeerA.and the Canadian Streptococcal Study Group. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—A comparative observational study.Clinical Infectious Diseases1999; 28: 800–807.
10.
FisherC.J.Jr., HorowitzB.Z., AlbertsonT.E.Cardiorespiratory failure in toxic shock syndrome: Effect of dobutamine.Crit Care Med1985; 13: 160–165.
11.
ChesneyP.J., CrassB.A., PolyakM.B.Toxic shock syndrome: Management and long-term sequelae.Ann Int Med1982; 96: 847–851.
12.
BohachG.A., HovdeC.J., HandleyJ.P., SchlievertP.M.Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.Infect Immun1988; 56: 400–404.
13.
MollnesT.E., HaroeM.Clinical immunology.Br Med J1996; 312: 1465–1469.
14.
BianchineP.J.Use of immune globulin intravenous (human) to prevent infection in the multiple trauma patient.Crit Care Med2000, 28: 254–255.
15.
AlejandriaM.M., LansangM.A., DansL.F., MantaringJ.B.V.Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review).In: The Cochrane Library, Issue 4, 2001.
16.
WerdanK., PilzG and the SBITs study group. Polyvalent immune globulins (abstract).Shock1997; 7, Suppl 5: 1918.
ChiuC.H., OuJ.T., ChangK.S., LinT.Y.Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.Infection1997; 25: 47–48.
19.
PerezC.M., KubakB.M., CryerH.G., SalehmugodamS., VespaP., FarmerD.Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.Am J Med1997; 102: 111–113.
20.
OnoY., MegumiM., SugiyamaH.A case report of toxic shock-like syndrome due to group A streptococcal infection in an alcoholic.Kansenshogaku Zasshi1995; 69: 597–601.
21.
TurbiakT.W., ReichJ.J.Bacterial infections. In: RosenP. (ed). Emergency Medicine. Concepts and clinical practice, 4th Edition.Mosby, St. Louis1998; 2504–2531.
22.
Working group on severe streptococcal infections.Defining the group A streptococcal toxic shock syndrome.JAMA1993; 269: 390–391.
